Enxaqueca: estratégias para reduzir a dor e melhorar sua vida
Palavras-chave:
Enxaqueca-diagnóstico, Enxaqueca-prevenção, Enxaqueca-tratamentoSinopse
Globalmente, a dor de cabeça afeta de maneira mais significativa metade da população adulta, com uma significativa parcela - entre 10 a 20% - sofrendo de enxaqueca. Adicionalmente, 3% da população enfrenta cefaleia crônica, uma condição marcada pela ocorrência de dores de cabeça em 15 ou mais dias por mês, durante um período de três meses ou mais. Este panorama destaca a extensão e a seriedade das cefaleias como questões de saúde pública mundial (Jensen and Stovner, 2008, Ashina, 2020).
A enxaqueca, uma das condições mais comuns e debilitantes da era moderna, frequentemente não recebe a atenção adequada de órgãos públicos de saúde e é subvalorizada pela população em geral. Indivíduos que sofrem dessa condição enfrentam não apenas a dor física intensa, mas também uma significativa discriminação social (Parikh and Young, 2019). No ambiente de trabalho, por exemplo, essas pessoas podem ser estigmatizadas e ridicularizadas por colegas e superiores, que muitas vezes desvalorizam seu sofrimento através de comentários insensíveis ou brincadeiras de mau gosto (Shapiro et al., 2024). Essa falta de compreensão pode levar a consequências graves, como perda de emprego, salários mais baixos e competição desleal por promoções, aumentando o estresse e agravando ainda mais a doença (Gross et al., 2023).
Além dos desafios profissionais, o impacto emocional da enxaqueca é profundo. Muitos pacientes desenvolvem baixa autoestima, depressão e ansiedade significativas (Aydemir et al., 2011). O medo constante de enfrentar uma nova crise de enxaqueca não se limita ao temor da dor (Hursey and Jacks, 1992, Klan et al., 2022), mas também ao receio de serem novamente marginalizados ou tachados como preguiçosos ou pouco produtivos. Essa situação cria um ciclo vicioso de estresse e ansiedade, que não só perpetua, mas também pode intensificar a frequência e gravidade das crises de enxaqueca, comprometendo seriamente a qualidade de vida desses indivíduos (Seng et al., 2022, Lipton et al., 2023). É crucial que haja uma maior conscientização sobre a enxaqueca como uma condição médica séria, necessitando de empatia, apoio adequado e reconhecimento tanto no ambiente de trabalho quanto no contexto social mais amplo.
Neste livro, o objetivo é fornecer informações claras e acessíveis sobre a enxaqueca, apoiadas por bases científicas e referências bibliográficas detalhadas para aqueles que desejam aprofundar-se no assunto. Utilizando uma linguagem simples e direta, este volume oferece uma visão abrangente sobre o que é a enxaqueca, seus aspectos clínicos, os sintomas associados e as estratégias de avaliação do paciente, incluindo exames de imagem, questionários e análises laboratoriais.
Além disso, as opções de tratamento são discutidas, tanto farmacológicas quanto não farmacológicas, e orientações para a adoção de um estilo de vida mais saudável são fornecidas, podendo reduzir significativamente o impacto e a frequência das crises de enxaqueca. Ao ler este livro, espera-se que aqueles que enfrentam essa doença encontrem as ferramentas necessárias para compreender melhor sua condição e descobrir maneiras de viver com menos dor.
Referências
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38, 1-211.
Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol, 23, 344-381.
ALLEN, S. M., MOOKADAM, F., CHA, S. S., FREEMAN, J. A., STARLING, A. J. & MOOKADAM, M. 2018. Greater Occipital Nerve Block for Acute Treatment of Migraine Headache: A Large Retrospective Cohort Study. J Am Board Fam Med, 31, 211-218.
ALMEIDA, L. C. A. & VALENÇA, M. M. 2017. "Um mundo em câmera lenta" como manifestação da Síndrome de Alice no País das Maravilhas: um relato de caso. Headache Medicine, 134-137.
AMORIM, J. A., GOMES DE BARROS, M. V. & VALENCA, M. M. 2012. Post-dural (post-lumbar) puncture headache: risk factors and clinical features. Cephalalgia, 32, 916-23.
AMORIM, J. A. & VALENCA, M. M. 2008. Postdural puncture headache is a risk factor for new postdural puncture headache. Cephalalgia, 28, 5-8.
ANDRADE, C. 2021. Ginger for Migraine. J Clin Psychiatry, 82.
ANTEMIE, R. G., SAMOILA, O. C. & CLICHICI, S. V. 2023. Blue Light-Ocular and Systemic Damaging Effects: A Narrative Review. Int J Mol Sci, 24.
ARAB, A., KHORVASH, F., KARIMI, E., HADI, A. & ASKARI, G. 2023. Associations between adherence to Mediterranean dietary pattern and frequency, duration, and severity of migraine headache: A cross-sectional study. Nutr Neurosci, 26, 1-10.
ARAGÃO, M. D. F. V. V., ARAÚJO, L. C. & VALENÇA, M. M. 2022. Headache and neuroimaging findings in conditions of cerebrospinal fluid (CSF) circulation disorders: in hydrocephalus, pseudotumor cerebri, and CSF hypotension syndrome. Headache Medicine, 12, 287-292.
ASHINA, M. 2020. Migraine. N Engl J Med, 383, 1866-1876.
AYDEMIR, N., OZKARA, C., UNSAL, P. & CANBEYLI, R. 2011. A comparative study of health related quality of life, psychological well-being, impact of illness and stigma in epilepsy and migraine. Seizure, 20, 679-85.
BAGBY, R. M., PARKER, J. D. & TAYLOR, G. J. 1994. The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure. J Psychosom Res, 38, 23-32.
BAKIRHAN, H., YILDIRAN, H. & UYAR CANKAY, T. 2022. Associations between diet quality, DASH and Mediterranean dietary patterns and migraine characteristics. Nutr Neurosci, 25, 2324-2334.
BAUGHMAN, D., BOUDREAU, S. A., POWELSON, E. B., MOLINA OCHOA, D., ARENDT-NIELSEN, L. & CURATOLO, M. 2020. Modulation of pain areas by greater occipital nerve block in chronic daily headache. Eur J Anaesthesiol, 37, 248-251.
BOTTIROLI, S., GALLI, F., VIANA, M., SANCES, G. & TASSORELLI, C. 2018. Traumatic Experiences, Stressful Events, and Alexithymia in Chronic Migraine With Medication Overuse. Front Psychol, 9, 704.
BRAGANZA, D. L., FITZPATRICK, L. E., NGUYEN, M. L. & CROWE, S. F. 2022. Interictal Cognitive Deficits in Migraine Sufferers: A Meta-Analysis. Neuropsychol Rev, 32, 736-757.
BUNNER, A. E., AGARWAL, U., GONZALES, J. F., VALENTE, F. & BARNARD, N. D. 2014. Nutrition intervention for migraine: a randomized crossover trial. J Headache Pain, 15, 69.
BURCH, R. 2022. A non-oral gepant for acute treatment of migraine. Headache, 62, 1075-1076.
BUSHMAN, E. T., BLANCHARD, C. T., COZZI, G. D., DAVIS, A. M., HARPER, L., ROBBINS, L. S., JONES, B., SZYCHOWSKI, J. M., DIGRE, K. B., CASEY, B. M., TITA, A. T. & SINKEY, R. G. 2023. Occipital Nerve Block Compared With Acetaminophen and Caffeine for Headache Treatment in Pregnancy: A Randomized Controlled Trial. Obstet Gynecol, 142, 1179-1188.
BUZZI, M. G., COLOGNO, D., FORMISANO, R. & ROSSI, P. 2005. Prodromes and the early phase of the migraine attack: therapeutic relevance. Funct Neurol, 20, 179-83.
CHIANG, M. C., DUMITRASCU, O. M., CHHABRA, N. & CHIANG, C. C. 2021. Migraine with Visual aura and the Risk of Stroke- a Narrative Review. J Stroke Cerebrovasc Dis, 30, 106067.
CHO, K. H., KIM, J. E., BAHUGUNA, A. & KANG, D. J. 2023. Long-Term Supplementation of Ozonated Sunflower Oil Improves Dyslipidemia and Hepatic Inflammation in Hyperlipidemic Zebrafish: Suppression of Oxidative Stress and Inflammation against Carboxymethyllysine Toxicity. Antioxidants (Basel), 12.
CHOWDHURY, D., DATTA, D. & MUNDRA, A. 2021. Role of Greater Occipital Nerve Block in Headache Disorders: A Narrative Review. Neurol India, 69, S228-S256.
CHRONICLE, E. & MULLENERS, W. 2004. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev, CD003226.
CUADRADO, M. L., YOUNG, W. B., FERNANDEZ-DE-LAS-PENAS, C., ARIAS, J. A. & PAREJA, J. A. 2008. Migrainous corpalgia: body pain and allodynia associated with migraine attacks. Cephalalgia, 28, 87-91.
CUVELLIER, J. C. 2019. Pediatric vs. Adult Prodrome and Postdrome: A Window on Migraine Pathophysiology? Front Neurol, 10, 199.
DAOU, M. & VGONTZAS, A. 2024. Sleep Symptoms in Migraine. Curr Neurol Neurosci Rep, 24, 245-254.
DE FALCO, F. A. & DE FALCO, A. 2015. Migraine with aura: which patients are most at risk of stroke? Neurol Sci, 36 Suppl 1, 57-60.
DE OLIVEIRA, D. A. & VALENCA, M. M. 2012. The characteristics of head pain in response to an experimental cold stimulus to the palate: An observational study of 414 volunteers. Cephalalgia, 32, 1123-30.
DE VRIES LENTSCH, S., VAN DER AREND, B. W. H., DE BOER, I., VAN ZWET, E. W., MAASSENVANDENBRINK, A. & TERWINDT, G. M. 2024. Depression and treatment with anti-calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine. Eur J Neurol, 31, e16106.
DO, T. P., LA COUR KAROTTKI, N. F. & ASHINA, M. 2021. Updates in the Diagnostic Approach of Headache. Curr Pain Headache Rep, 25, 80.
DODICK, D. W., GOADSBY, P. J., SCHWEDT, T. J., LIPTON, R. B., LIU, C., LU, K., YU, S. Y., SEVERT, L., FINNEGAN, M. & TRUGMAN, J. M. 2023. Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA. Lancet, 402, 2307-2316.
DOLATI, S., RIKHTEGAR, R., MEHDIZADEH, A. & YOUSEFI, M. 2020. The Role of Magnesium in Pathophysiology and Migraine Treatment. Biol Trace Elem Res, 196, 375-383.
EDMEADS, J., LAINEZ, J. M., BRANDES, J. L., SCHOENEN, J. & FREITAG, F. 2001. Potential of the Migraine Disability Assessment (MIDAS) Questionnaire as a public health initiative and in clinical practice. Neurology, 56, S29-34.
ERCAN, M. & ERTEKIN, A. 2024. The effect of simultaneous administration of occipital nerve block and cervical myofascial trigger point injection (MTrPI) on headache parameters in chronic migraine patients. Ir J Med Sci.
ESTAVE, P. M., BEEGHLY, S., ANDERSON, R., MARGOL, C., SHAKIR, M., GEORGE, G., BERGER, A., O'CONNELL, N., BURCH, R., HAAS, N., POWERS, S. W., SENG, E., BUSE, D. C., LIPTON, R. B. & WELLS, R. E. 2021. Learning the full impact of migraine through patient voices: A qualitative study. Headache, 61, 1004-1020.
FILTEAU, S. M., LIETZ, G., MULOKOZI, G., BILOTTA, S., HENRY, C. J. & TOMKINS, A. M. 1999. Milk cytokines and subclinical breast inflammation in Tanzanian women: effects of dietary red palm oil or sunflower oil supplementation. Immunology, 97, 595-600.
FLAMER, D., ALAKKAD, H., SONEJI, N., TUMBER, P., PENG, P., KARA, J., HOYDONCKX, Y. & BHATIA, A. 2019. Comparison of two ultrasound-guided techniques for greater occipital nerve injections in chronic migraine: a double-blind, randomized, controlled trial. Reg Anesth Pain Med, 44, 595-603.
FLORENCIO, L. L., CHAVES, T. C., BRANISSO, L. B., GONCALVES, M. C., DACH, F., SPECIALI, J. G., BIGAL, M. E. & BEVILAQUA-GROSSI, D. 2012. 12 item allodynia symptom checklist/Brasil: cross-cultural adaptation, internal consistency and reproducibility. Arq Neuropsiquiatr, 70, 852-6.
FREITAS, D. D. S., COSTA, C. N. B. D., SIQUEIRA, G. R., VALENÇA, M. M. & OLIVEIRA, D. A. D. 2013. Sintomatologia depressiva em adolescentes com cefaleia primária. Headache Medicine, 13-19.
GHIGGIA, A., BOTTIROLI, S., LINGIARDI, V., TASSORELLI, C., GALLI, F. & CASTELLI, L. 2022. Alexithymia and psychological distress in fibromyalgia and chronic migraine: A cross-sectional study. J Psychosom Res, 163, 111048.
GOKDENIZ, T., KALAYCIOGLU, E. & ALTINTAS, B. 2020. Assessment of cardiac mechanics and biomarkers during headache attack in migraine patients with aura: a prospective study. Int J Cardiovasc Imaging, 36, 1321-1331.
GOOD, P. A., TAYLOR, R. H. & MORTIMER, M. J. 1991. The use of tinted glasses in childhood migraine. Headache, 31, 533-6.
GROSS, E., RUIZ DE LA TORRE, E. & MARTELLETTI, P. 2023. The Migraine Stigma Kaleidoscope View. Neurol Ther, 12, 703-709.
HANS, A., STONNINGTON, C. M., ZHANG, N., BUTTERFIELD, R. & FRIEDMAN, D. I. 2023. The impact of resilience on headache disability as measured by the Migraine Disability Assessment (MIDAS). Headache, 63, 743-750.
HSU, Y. Y., CHEN, C. J., WU, S. H. & CHEN, K. H. 2023. Cold intervention for relieving migraine symptoms: A systematic review and meta-analysis. J Clin Nurs, 32, 2455-2465.
HURSEY, K. G. & JACKS, S. D. 1992. Fear of pain in recurrent headache sufferers. Headache, 32, 283-6.
IANNONE, L. F., FATTORI, D., BENEMEI, S., CHIARUGI, A., GEPPETTI, P. & DE CESARIS, F. 2022. Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score. CNS Drugs, 36, 191-202.
JENSEN, R. & STOVNER, L. J. 2008. Epidemiology and comorbidity of headache. Lancet Neurol, 7, 354-61.
JESUS, A. C., OLIVEIRA, H. A., PAIXAO, M. O., FRAGA, T. P., BARRETO, F. J. & VALENCA, M. M. 2009. Clinical description of hemodialysis headache in end-stage renal disease patients. Arq Neuropsiquiatr, 67, 978-81.
KALANTAR HORMOZI, B., TAVOLI, A. & ABDOLLAHI, A. 2022. Perceived Parental Styles and Alexithymia in Adult Iranian Migraine Patients: The Mediating Role of Emotional Schemas. J Genet Psychol, 183, 250-262.
KARIMI, E., TIRANI, S. A., AZIMI, E. S., ASKARI, G., AS'HABI, A. & ARAB, A. 2023. Is there an association between a plant-based eating pattern and clinical findings of a migraine headache? Front Nutr, 10, 1117740.
KATSARAVA, Z., BUSE, D. C., LEROUX, E., LANTERI-MINET, M., SAKAI, F., MATHARU, M. S., ADAMS, A. M., CARR, K., FANNING, K. M. & LIPTON, R. B. 2024. Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study. Cephalalgia, 44, 3331024241274343.
KELMAN, L. 2006. The postdrome of the acute migraine attack. Cephalalgia, 26, 214-20.
KHALID, M. M., GALUSKA, M. A. & HAMILTON, R. J. 2024. Beta-Blocker Toxicity.
KHORSHA, F., MIRZABABAEI, A., TOGHA, M. & MIRZAEI, K. 2020. Association of drinking water and migraine headache severity. J Clin Neurosci, 77, 81-84.
KIRKPATRICK, D. L., TOWNSEND, T., WALTER, C., CLARK, L., ALLI, A., FAHRBACH, T., MADARANG, E. J., LEMONS, S., REEVES, A. & COLLINS, Z. 2020. Lidocaine Versus Bupivacaine in the Treatment of Headache with Intranasal Sphenopalatine Nerve Block. Pain Physician, 23, 423-428.
KLAN, T., BRASCHER, A. K., KLEIN, S., DIEZEMANN-PROSSDORF, A., GUTH, A. L., GAUL, C. & WITTHOFT, M. 2022. Assessing attack-related fear in headache disorders-Structure and psychometric properties of the Fear of Attacks in Migraine Inventory. Headache, 62, 294-305.
KRYMCHANTOWSKI, A., JEVOUX, C., SILVA-NETO, R. P. & KRYMCHANTOWSKI, A. G. 2020. Migraine Treatment in Emergency Departments of Brazil: A Retrospective Study of 2 Regions. Headache, 60, 2413-2420.
KRYMCHANTOWSKI, A. V., JEVOUX, C., KRYMCHANTOWSKI, A. G. & SILVA-NETO, R. P. 2023. Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study. Front Neurol, 14, 1129439.
KRYMCHANTOWSKI, A. V., TEPPER, S. J., JEVOUX, C. & VALENCA, M. 2017. Medication-Overuse Headache: Protocols and Outcomes in 149 Consecutive Patients in a Tertiary Brazilian Headache Center. Headache, 57, 87-96.
LEE, W., SHIN, H. J., MIN, I. K., KIM, C. S., KIM, K. M., HEO, K. & CHU, M. K. 2024. Shared comorbidity of depression, migraine, insomnia, and fibromyalgia in a population-based sample. J Affect Disord, 354, 619-626.
LI, Y., LUO, G., ZHOU, L., WANG, X., LIU, H., ZHANG, Y. & YAN, M. 2024. Mediators of the association between depression and migraine: a mendelian randomization study. Front Genet, 15, 1326817.
LIMA CARVALHO, M. F., DE MEDEIROS, J. S. & VALENCA, M. M. 2017. Headache in recent onset hypothyroidism: Prevalence, characteristics and outcome after treatment with levothyroxine. Cephalalgia, 37, 938-946.
LIMA, M. C. M., MAIOLI, G. S. & VALENÇA, M. M. 2022. Red flags for secondary headaches: challenges in clinical practice. Headache Medicine, 13, 242-248.
LIPTON, R. B., POZO-ROSICH, P., ORR, S. L., REED, M. L., FANNING, K. M., DABRUZZO, B. & BUSE, D. C. 2023. Impact of monthly headache days on migraine-related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. Headache, 63, 1448-1457.
LUCIANI, R., CARTER, D., MANNIX, L., HEMPHILL, M., DIAMOND, M. & CADY, R. 2000. Prevention of migraine during prodrome with naratriptan. Cephalalgia, 20, 122-6.
MAIER, J. A., PICKERING, G., GIACOMONI, E., CAZZANIGA, A. & PELLEGRINO, P. 2020. Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate. Nutrients, 12.
MARTINS, H. A., RIBAS, V. R., LIMA, M. D., OLIVEIRA, D. A., VIANA, M. T., RIBAS, K. H. & VALENCA, M. M. 2010. Headache precipitated by Valsalva maneuvers in patients with congenital Chiari I malformation. Arq Neuropsiquiatr, 68, 406-9.
MARTINS, H. A., RIBAS, V. R., MARTINS, B. B., RIBAS RDE, M. & VALENCA, M. M. 2009. Post-traumatic headache. Arq Neuropsiquiatr, 67, 43-5.
MARTINS, H. A. D. L., MARTINS, B. B. M., SANTOS, C. C. D., PONTES, D. J., OLIVEIRA, D. A. D. & VALENÇA, M. M. 2021. Persistent idiopathic facial pain associated with borderline personality disorder: a case report. Headache Medicine, 12, 59-63.
MARTINS, H. A. L., MARTINS, B. B. M., RIBAS, V. R., BERNARDINO, S. N., DE OLIVEIRA, D. A., SILVA, L. C., SOUGEY, E. B. & VALENCA, M. M. 2012. Life quality, depression and anxiety symptoms in chronic post-traumatic headache after mild brain injury. Dement Neuropsychol, 6, 53-58.
MARTINS, L. B., RODRIGUES, A., RODRIGUES, D. F., DOS SANTOS, L. C., TEIXEIRA, A. L. & FERREIRA, A. V. M. 2019. Double-blind placebo-controlled randomized clinical trial of ginger ( Zingiber officinale Rosc.) addition in migraine acute treatment. Cephalalgia, 39, 68-76.
MEHRAMIRI, A., SHALILAHMADI, D., MOHAMADIANINEJAD, S. E., KOUTI, L. & HOSSEINPOUR, Y. 2024. The Effect of Melatonin on Reducing the Frequency and Severity of Migraine Attacks: A Double-Blind, Randomized Clinical Trial. Iran J Med Sci, 49, 313-321.
MELHADO, E. M., THIERS RISTER, H. L., GALEGO, D. R., DE OLIVEIRA, A. B., BUTTARELLO, I. A., BELUCIO, I. S., OLIVEIRA MARCOS, J. M., XAVIER, M. L. T. & PERES, M. F. P. 2020. Allodynia in Menstrually Related Migraine: Score Assessment by Allodynia Symptom Checklist (ASC-12). Headache, 60, 162-170.
METIN, K. M., DILEK, S. S., KARADUMAN, Y., SERCE, A., TAKMAZ, S. A. & INAN, L. E. 2023. The effects of greater occipital nerve blockage with lidocaine on sleep characteristics in chronic migraine patients. Clin Neurol Neurosurg, 231, 107826.
NATALUCCI, G., FAEDDA, N., QUINZI, A., ALUNNI FEGATELLI, D., VESTRI, A., TURTURO, G., VERDECCHIA, P., BELLINI, B., PIRISI, C., CALDERONI, D., GIANNOTTI, F., CERUTTI, R., GIACOLINI, T. & GUIDETTI, V. 2019. Alexithymia, Metacognition, and Theory of Mind in Children and Preadolescents With Migraine Without Aura (MWoA): A Case-Control Study. Front Neurol, 10, 774.
OLESEN, J. 2018. International Classification of Headache Disorders. Lancet Neurol, 17, 396-397.
ORNELLO, R., LAMBRU, G., CAPONNETTO, V., FRATTALE, I., DI FELICE, C., PISTOIA, F. & SACCO, S. 2020. Efficacy and safety of greater occipital nerve block for the treatment of cluster headache: a systematic review and meta-analysis. Expert Rev Neurother, 20, 1157-1167.
OZARSLAN, M., MATUR, Z., TUZUN, E. & OGE, A. E. 2022. Cutaneous allodynia and thermal thresholds in chronic migraine: The effect of onabotulinumtoxinA. Clin Neurol Neurosurg, 220, 107357.
PARIKH, S. K. & YOUNG, W. B. 2019. Migraine: Stigma in Society. Curr Pain Headache Rep, 23, 8.
PATEL, K. M., POPATBHAI, K. M., XAVIER, R., ARAMIN, M. A. S., FARIS, K. J. F., MATEEN, M. A., PRAJWAL, P., MARSOOL, M. D. M., SHEIKH, H. & MOHAMED, E. 2024. Comparison of the efficacy of propranolol versus amitriptyline as monotherapy for prophylaxis of migraine. J Family Med Prim Care, 13, 699-703.
PENARROCHA, M., BANDRES, A. & BAGAN, J. V. 2004. Lower-half facial migraine: a report of 11 cases. J Oral Maxillofac Surg, 62, 1453-6.
PERES, M. F., MASRUHA, M. R., ZUKERMAN, E., MOREIRA-FILHO, C. A. & CAVALHEIRO, E. A. 2006. Potential therapeutic use of melatonin in migraine and other headache disorders. Expert Opin Investig Drugs, 15, 367-75.
PERES, M. F., VALENCA, M. M., AMARAL, F. G. & CIPOLLA-NETO, J. 2019. Current understanding of pineal gland structure and function in headache. Cephalalgia, 39, 1700-1709.
PERES, M. F., ZUKERMAN, E., DA CUNHA TANURI, F., MOREIRA, F. R. & CIPOLLA-NETO, J. 2004. Melatonin, 3 mg, is effective for migraine prevention. Neurology, 63, 757.
PERES, M. F. P., VALENÇA, M. M., MARTINS, R. B. & ANDRADE, J. R. D. 2024. Unlocking Insights: Harnessing AI for Headache Awareness and Understanding. Headache Medicine, 15, 1.
POHL, H., DO, T. P., GARCIA-AZORIN, D., HANSEN, J. M., KRISTOFFERSEN, E. S., NELSON, S. E., OBERMANN, M., SANDOR, P. S., SCHANKIN, C. J., SCHYTZ, H. W., SINCLAIR, A., SCHOONMAN, G. G. & GANTENBEIN, A. R. 2021. Green Flags and headache: A concept study using the Delphi method. Headache, 61, 300-309.
PRIETO PERES, M. F., LIMA, T. A. C. D. & VALENÇA, M. M. 2021. International Classification of Headache Disorders - ICHD-4. Will medication-overuse headache survive? Headache Medicine, 12, 72-74.
PRIETO PERES, M. F. & VALENCA, M. M. 2010. Headache endocrinological aspects. Handb Clin Neurol, 97, 717-37.
REIS, R. S. D., BOTTER, R. L. G., FERREIRA, M. R. D. S., SOUZA, S. L. D., ANDRADE, J. R. D., CHRISTENSEN, S. L. T. & VALENÇA, M. M. 2023. Presence of mast cells in the rat pericranium – a tissue very sensitive to pain. Headache Medicine, 14, 65-68.
RIBEIRO DOS SANTOS, E. R. R., OLIVEIRA, D. A. D., LEITE, A. F. B., ROCHA FILHO, P. A. S. & VALENÇA, M. M. 2021. Headache catastrophization and its relationship with disability, depression, anxiety, stress and sleep quality. Headache Medicine, 12, 118-127.
ROBERTS, A. C. 2003. Migraine and its connections in neurology and psychiatry. CNS Spectr, 8, 635; author reply 635.
ROTA, E., CAVAGNETTO, E., IMMOVILLI, P., FROLA, E., SALARI, P., MORELLI, N. & BATTAGGIA, A. 2024. Alexithymia Increases Pericranial and Cervical Muscle Tenderness in Women with Migraine. J Clin Med, 13.
ROZEN, T. D. 2004. Migraine prodrome: a nose on a face. Lancet, 363, 517.
SAHIN, O., GUNES, M., SAHIN, E. H. K. & DONMEZ, R. 2024. The effect of greater occipital nerve block on amplification of somatic symptoms and anxiety and depression levels in chronic migraine. Acta Neurol Belg.
SANTOS, E. R. R. D., LAL, A., TARDIEUX, F. M., RIBEIRO, E. C. D. O., FORTES, H. M. S. & VALENÇA, M. M. 2023. External compression headache during Covid-19 pandemic: a neglected entity. Headache Medicine, 14, 77-82.
SENG, E. K., SHAPIRO, R. E., BUSE, D. C., ROBBINS, M. S., LIPTON, R. B. & PARKER, A. 2022. The unique role of stigma in migraine-related disability and quality of life. Headache, 62, 1354-1364.
SERVA, W. A., SERVA, V. M., CAMINHA MDE, F., FIGUEIROA, J. N., SERVA, G. B. & VALENCA, M. M. 2012. Exclusive breastfeeding protects against postpartum migraine recurrence attacks? Arq Neuropsiquiatr, 70, 428-34.
SERVA, W. A., SERVA, V. M., DE FATIMA COSTA CAMINHA, M., FIGUEIROA, J. N., ALBUQUERQUE, E. C., SERVA, G. B., BELO, M. P., FILHO, M. B. & VALENCA, M. M. 2011. Course of migraine during pregnancy among migraine sufferers before pregnancy. Arq Neuropsiquiatr, 69, 613-9.
SHAHROKHI, M. & GUPTA, V. 2024. Propranolol.
SHAPIRO, R. E., NICHOLSON, R. A., SENG, E. K., BUSE, D. C., REED, M. L., ZAGAR, A. J., ASHINA, S., MUENZEL, E. J., HUTCHINSON, S., PEARLMAN, E. M. & LIPTON, R. B. 2024. Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life: Results of the OVERCOME (US) Study. Neurology, 102, e208074.
SILVA-NETO, R. P., PERES, M. F. & VALENCA, M. M. 2014. Odorant substances that trigger headaches in migraine patients. Cephalalgia, 34, 14-21.
SILVA-NETO, R. P., RODRIGUES, A. B., CAVALCANTE, D. C., FERREIRA, P. H., NASI, E. P., SOUSA, K. M., PERES, M. F. & VALENCA, M. M. 2017. May headache triggered by odors be regarded as a differentiating factor between migraine and other primary headaches? Cephalalgia, 37, 20-28.
SIQUEIRA, P. D. T. V. V., ANDRADE-VALENÇA, L. P. A. D., ANDRADE, J. R. & VALENÇA, M. M. 2021. Pediatric patients at a high risk of headache of ocular origin: the HAMS Score (Hyperopia, Astigmatism, Myopia, and Strabismus). Headache Medicine, 12, 134-140.
SONG, T. J., KIM, B. S. & CHU, M. K. 2020. Therapeutic role of melatonin in migraine prophylaxis: Is there a link between sleep and migraine? Prog Brain Res, 255, 343-369.
STEWART, W. F., LIPTON, R. B., KOLODNER, K. B., SAWYER, J., LEE, C. & LIBERMAN, J. N. 2000. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain, 88, 41-52.
STEWART, W. F., LIPTON, R. B., WHYTE, J., DOWSON, A., KOLODNER, K., LIBERMAN, J. N. & SAWYER, J. 1999. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology, 53, 988-94.
SUZUKI, K., SUZUKI, S., HARUYAMA, Y., FUNAKOSHI, K., FUJITA, H., SAKURAMOTO, H., HAMAGUCHI, M., KOBASHI, G. & HIRATA, K. 2024. Associations between the burdens of comorbid sleep problems, central sensitization, and headache-related disability in patients with migraine. Front Neurol, 15, 1373574.
TASSORELLI, C., ONISHCHENKO, K., HALKER SINGH, R. B., DUAN, M., DUPONT-BENJAMIN, L., HEMSTOCK, M., VOLLER, C., MCALLISTER, P., NAHAS, S. J., GANDHI, P. & AILANI, J. 2024. Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis. Cephalalgia, 44, 3331024241235156.
TATSUMOTO, M., SUZUKI, E., NAGATA, M., SUZUKI, K. & HIRATA, K. 2023. Prophylactic Treatment for Patients with Migraine Using Blue Cut for Night Glass. Intern Med, 62, 849-854.
TSENG, P. T., ZENG, B. Y., CHEN, J. J., KUO, C. H., ZENG, B. S., KUO, J. S., CHENG, Y. S., SUN, C. K., WU, Y. C., TU, Y. K., STUBBS, B., CARVALHO, A. F., LIANG, C. S., CHEN, T. Y., HSU, C. W., SUEN, M. W., YANG, C. P., HSU, S. P., CHEN, Y. W., SHIUE, Y. L., HUNG, C. M., SU, K. P. & LIN, P. Y. 2024. High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis. Adv Nutr, 15, 100163.
UCLER, S., COSKUN, O., INAN, L. E. & KANATLI, Y. 2006. Cold Therapy in Migraine Patients: Open-label, Non-controlled, Pilot Study. Evid Based Complement Alternat Med, 3, 489-93.
URITS, I., VISWANATH, O., ORHURHU, V., PETRO, J. & CAI, V. 2019. Sphenopalatine ganglion block in combination with greater and lesser occipital nerve blocks for the management of post dural puncture headache. J Clin Anesth, 52, 69-70.
VALENCA, M. M. 2007. Intractable headache criteria. Cephalalgia, 27, 858-9; author reply 859.
VALENCA, M. M. 2012. Bath-related headache induced by varenicline. Arq Neuropsiquiatr, 70, 908.
VALENCA, M. M. 2015. The brazilian contribution to the diagnosis and treatment of headache disorders. Headache, 55 Suppl 1, 1-3.
VALENÇA, M. M. 2014. Use of medicinal plants by the population to treat headache. Headache Medicine, 5, 32.
VALENÇA, M. M. 2023a. The challenges of migraine care in Brazil: from tertiary centers to public health realities. Headache Medicine, 14, 174-175.
VALENÇA, M. M. 2023b. Headache attributed to spontaneous intracranial hypotension and associated possible causes. Headache Medicine, 14, 69-71.
VALENÇA, M. M. 2023c. State-of-the-art in the acute and preventive treatment of migraine from children to adults - a Special Collection. Headache Medicine, 14, 131-132.
VALENCA, M. M., AMORIM, J. A. & MOURA, T. P. 2012. Why don't all individuals who undergo dura mater/arachnoid puncture develop postdural puncture headache? Anesth Pain Med, 1, 207-9.
VALENCA, M. M., ANDRADE-VALENCA, L. P., BORDINI, C. A. & SPECIALI, J. G. 2008. Thunderclap headache attributed to reversible cerebral vasoconstriction: view and review. J Headache Pain, 9, 277-88.
VALENCA, M. M., ANDRADE-VALENCA, L. P., MARTINS, C., DE FATIMA VASCO ARAGAO, M., BATISTA, L. L., PERES, M. F. & DA SILVA, W. F. 2007a. Cluster headache and intracranial aneurysm. J Headache Pain, 8, 277-82.
VALENÇA, M. M. & ANDRADE, J. R. D. 2024. Art and relief: how AI portrays success in treating headaches. Headache Medicine, 15, 115-116.
VALENÇA, M. M., BEM JUNIOR, L. S., SILVA, A. C. V. D., SILVA, U. A. V. D., VALENÇA, M. A., SILVA, A. H. T. T. D., CARVALHO, D. E. D., FORTES, H. M. S., VALENÇA, M. F. & ANDRADE-VALENÇA, L. P. A. D. 2022a. Chronic subdural hematoma that developed after a diagnostic lumbar puncture: headache worsens with bilateral compression of jugular veins (Queckenstedt’s maneuver). Headache Medicine, 12, 346-348.
VALENCA, M. M., DA SILVA, A. A. & BORDINI, C. A. 2015a. Headache research and medical practice in Brazil: an historical overview. Headache, 55 Suppl 1, 4-31.
VALENCA, M. M. & DE OLIVEIRA, D. A. 2016. The Frequent Unusual Headache Syndromes: A Proposed Classification Based on Lifetime Prevalence. Headache, 56, 141-52.
VALENCA, M. M., DE OLIVEIRA, D. A. & MARTINS, H. A. 2015b. Alice in Wonderland Syndrome, Burning Mouth Syndrome, Cold Stimulus Headache, and HaNDL: Narrative Review. Headache, 55, 1233-48.
VALENÇA, M. M., E SOUSA, M. S. S. M., VALENÇA, M. A., CARVALHO, D. E. D., SILVA, A. H. T. T. D. & ANDRADE, J. R. D. 2022b. It is wrong to treat pain in CSF hypotension headache (post-lumbar puncture headache) to allow the patient to walk! Headache Medicine, 12, 293-298.
VALENÇA, M. M., FARIAS, H. S. S. D., ALMEIDA, L. C. A., FRANÇA, C. L. D. S., NOBRE, K. E. L., VALENÇA, M. A., SILVA JÚNIOR, M. L. D. M. & VALENÇA, L. P. A. D. A. 2017. Headache as a single clinical manifestation of a colloid cyst in the third ventricle. Headache Medicine, 25.
VALENCA, M. M., MEDEIROS, F. L., MARTINS, H. A., MASSAUD, R. M. & PERES, M. F. 2009. Neuroendocrine dysfunction in fibromyalgia and migraine. Curr Pain Headache Rep, 13, 358-64.
VALENÇA, M. M. & PERES, M. F. P. 2024a. Rethinking triage: enhancing the Manchester Triage System for headache emergencies. Headache Medicine, 15, 41-42.
VALENÇA, M. M. & PERES, M. F. P. 2024b. Urgent Need for Reform: Addressing the Inadequate Emergency Care for Headache Patients Under the Manchester Triage System. Headache Medicine, 15, 98-103.
VALENÇA, M. M., ROSAS, E. P., COSTA, R. F., SILVA, A. A. D., FERREIRA, M. R. D. S., REIS, R. S. D., VALENÇA, M. A. & ANDRADE- VALENÇA, L. P. A. D. 2019. Of the available triptans, which should be chosen and how should they be used? Headache Medicine, 10, 29-31.
VALENÇA, M. M. & SILVA-NÉTO, R. P. 2022. Menstrually-related stabbing headache in a patient without migraine: case report. Headache Medicine, 13, 291-295.
VALENÇA, M. M. & SILVA-NÉTO, R. P. 2023. Post-dural puncture headache. Headache Medicine, 14, 1-2.
VALENÇA, M. M., SILVA, A. H. T. T. D., MENDES, R. F. D. A., ANDRADE, P. H. P. D., SILVA, U. A. V. D., CARVALHO, D. E. D. & BATISTA, L. L. 2021a. Incidental intracranial saccular aneurysm in a patient with post-Covid-19 headache: What to do with the incidentaloma? Headache Medicine, 12, 64-68.
VALENÇA, M. M., SILVA, J. C. D., BARBOSA, M., VALENÇA, M. F., ALMEIDA, L. A., OLIVEIRA, M. C. M., FRANÇA, C. L. S., OLIVEIRA, R. R. B., SOARES, M. C., NUNES, E. C., COSTA, R. G., FARIAS, H. S. S., SARAIVA, I. S., HOLANDA, A. C., SOUZA JUNIOR, V. R., SILVA JÚNIOR, M. L. M., LIMA, M. C. C., BATISTA, M. A., TRAVASSOS, P. P., FERREIRA, U. S. M., ARAGÃO, M. D. F. V. & VALENÇA, L. P. A. A. 2014. Headache associated with compression of the third cranial nerve by an aneurysm of the posterior communicating artery. Headache Medicine, 5, 21-24.
VALENCA, M. M., SILVA, W. F., ANDRADE-VALENCA, L. P., BORDINI, C. A. & SPECIALI, J. G. 2007b. Cluster headache attacks in a woman previously struck by lightning: pathophysiology of the latent period. Arq Neuropsiquiatr, 65, 352-4.
VALENÇA, M. M., VALENÇA, C. F. & VALENÇA, M. F. 2016. Pain, anatomy and art. Headache Medicine, 7, 4-5.
VALENCA, M. M., VALENCA, L. P., BORDINI, C. A., DA SILVA, W. F., LEITE, J. P., ANTUNES-RODRIGUES, J. & SPECIALI, J. G. 2004. Cerebral vasospasm and headache during sexual intercourse and masturbatory orgasms. Headache, 44, 244-8.
VALENCA, M. M., VALENCA, L. P. & MENEZES, T. L. 2002. Computed tomography scan of the head in patients with migraine or tension-type headache. Arq Neuropsiquiatr, 60, 542-7.
VALENÇA, M. M., VALENÇA, M. F., ANDRADE, J. R., RIBEIRO, E. C. D. O., BEM JUNIOR, L. S., SILVA, A. C. V., MOTA, R. D. C. F. V., SILVA, U. A. V. D. & ANGELO JÚNIOR, J. R. L. 2021b. Brainstem tumor as a cause of headache triggered by Valsalva maneuver. Headache Medicine, 12, 70-71.
VALENÇA, M. M., VALENÇA, M. F., VALENÇA, M. A., LEITÃO, L. B., VALENÇA, L. P. A. D. A. & SILVA-NÉTO, R. P. 2023. Pain as an alarm signal in cervical carotid dissection: report of a case with catastrophic evolution. Headache Medicine, 13, 301-305.
WANDERLEY, D., VALENCA, M. M., DE SOUZA COSTA NETO, J. J., MARTINS, J. V., RAPOSO, M. C. F. & DE OLIVEIRA, D. A. 2020. Contract-relax technique compared to static stretching in treating migraine in women: A randomized pilot trial. J Bodyw Mov Ther, 24, 43-49.
WEINBERGER, A. H. & SENG, E. K. 2023. The Relationship of Tobacco Use and Migraine: A Narrative Review. Curr Pain Headache Rep, 27, 39-47.
YANG, Z., WANG, X., NIU, M., WEI, Q., ZHONG, H., LI, X., YUAN, W., XU, W., ZHU, S., YU, S., LIU, J., YAN, J., KANG, W. & HUANG, P. 2024. First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients. J Headache Pain, 25, 160.
YUAN, H. & SILBERSTEIN, S. D. 2024. How early can we treat migraine attacks? A perspective based on prodrome. Med, 5, 179-180.
Downloads
Publicado
julho 29, 2025
Copyright (c) 2025 Marcelo Moraes Valença
